Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NQO1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
NQO1 is a gene implicated in neurodegeneration research. Key relationships include: activates, therapeutic target, regulates. Associated with Als, Alzheimer, Anxiety. Connected to 113 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | NQO1 |
| Full Name | NAD(P)H Quinone Dehydrogenase 1 |
| Aliases | NAD(P |
| Chromosome | 16q22.1 |
| Function | NQO1 uses NAD(P)H as an electron donor to reduce quinones, preventing the formation of toxic semiquinone radicals. |
| Subcellular Localization | ** | Cytoplasm, also nucleus (minor) | |
| Molecular Weight | 31 kDa |
| Amino Acids | 274 aa |
| Pathways | Apoptosis, Ferroptosis |
| UniProt ID | P15559 |
| NCBI Gene ID | 1728 |
| Ensembl ID | ENSG00000100119 |
| OMIM | 125860 |
| GeneCards | NQO1 |
| Human Protein Atlas | NQO1 |
| Associated Diseases | Inflammation, Senescence |
| Interactions | AKT, ALZHEIMER, ALZHEIMER'S DISEASE, AND, ANTIOXIDANT GENES, APOPTOSIS |
| KG Connections | 280 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
NQO1["NQO1"] -->|"biomarker for"| Inflammation["Inflammation"]
NQO1["NQO1"] -->|"activates"| Inflammation_1["Inflammation"]
NQO1["NQO1"] -->|"activates"| Obesity["Obesity"]
NQO1["NQO1"] -->|"associated"| Inflammation_2["Inflammation"]
NQO1["NQO1"] -.->|"inhibits"| Stroke["Stroke"]
NQO1["NQO1"] -.->|"inhibits"| Ms["Ms"]
NRF2["NRF2"] -->|"activates"| NQO1["NQO1"]
NRF2_3["NRF2"] -->|"regulates"| NQO1["NQO1"]
GCLC["GCLC"] -->|"regulates"| NQO1["NQO1"]
GCLM["GCLM"] -->|"regulates"| NQO1["NQO1"]
style NQO1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Oxidative Stress Resistance | mediates | mechanism | 0.95 |
| cGAS-Type I Interferon Signaling | inhibits | pathway | 0.90 |
| Glioblastoma Stem Cells | associated_with | cell_type | 0.90 |
| ROS Levels | downregulates | process | 0.90 |
| Lipid Peroxidation | inhibits | process | 0.90 |
| redox homeostasis | regulates | process | 0.90 |
| NRF2 | activates | gene | 0.90 |
| oxidative stress response | participates_in | pathway | 0.80 |
| Glioblastoma | biomarker_for | disease | 0.80 |
| HO-1 | activates | gene | 0.80 |
| NRF2 | regulates | gene | 0.70 |
| Oxidative Stress | activates | pathway | 0.70 |
| AKT | activates | gene | 0.70 |
| PI3K | activates | gene | 0.70 |
| OXIDATIVE STRESS | activates | gene | 0.70 |
| APOPTOSIS | activates | gene | 0.70 |
| Apoptosis | activates | pathway | 0.70 |
| KEAP1 | activates | gene | 0.70 |
| CAT | activates | gene | 0.70 |
| amyloid clearance | regulates | mechanism | 0.70 |
| Oxidative Stress | associated_with | pathway | 0.70 |
| Inflammation | biomarker_for | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Addiction | therapeutic_target | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Anxiety | therapeutic_target | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Ovarian Cancer | regulates | disease | 0.65 |
| Stroke | therapeutic_target | disease | 0.65 |
| Epilepsy | therapeutic_target | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Neuroinflammation | regulates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Depression | therapeutic_target | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Lymphoma | activates | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Neurodegeneration | inhibits | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Obesity | activates | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| IPA | upregulates | compound | 0.95 |
| Mn And Fe | upregulates | compound | 0.95 |
| NFE2L2 | upregulates | gene | 0.85 |
| NRF2 | regulates | protein | 0.72 |
| NFE2L2 | regulates | gene | 0.70 |
| FSP1 | regulates | gene | 0.60 |
| GPX4 | regulates | gene | 0.60 |
| HO1 | activates | gene | 0.60 |
| DMT1 | regulates | gene | 0.60 |
| OXIDATIVE STRESS | biomarker_for | gene | 0.60 |
| BAX | activates | gene | 0.60 |
| INFLAMMATION | biomarker_for | gene | 0.60 |
| NAD | regulates | gene | 0.60 |
| NAD | expressed_in | gene | 0.60 |
| NADPH | activates | gene | 0.60 |
| GENES | biomarker_for | gene | 0.60 |
| AKT | therapeutic_target | gene | 0.60 |
| TNF | therapeutic_target | gene | 0.60 |
| FSP1 | inhibits | gene | 0.60 |
| CAT | causes | gene | 0.60 |
| GCLM | causes | gene | 0.60 |
| INFLAMMATION | inhibits | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| STROKE | therapeutic_target | gene | 0.60 |
| IL-6 | therapeutic_target | gene | 0.60 |
| DEPRESSION | therapeutic_target | gene | 0.60 |
| PARKINSON | therapeutic_target | gene | 0.60 |
| EPILEPSY | therapeutic_target | gene | 0.60 |
| ANXIETY | therapeutic_target | gene | 0.60 |
| VEGF | associated_with | gene | 0.60 |
| COX2 | inhibits | gene | 0.60 |
| PI3K | therapeutic_target | gene | 0.60 |
| GCLM | regulates | gene | 0.60 |
| HMOX1 | regulates | gene | 0.60 |
| LOX | activates | gene | 0.60 |
| HO1 | associated_with | gene | 0.60 |
| NRF2 | therapeutic_target | gene | 0.60 |
| PKC | therapeutic_target | gene | 0.60 |
| BDNF | associated_with | gene | 0.60 |
| STAT6 | associated_with | gene | 0.60 |
| REELIN | associated_with | gene | 0.60 |
| NOX2 | regulates | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| GCLC | regulates | gene | 0.60 |
| GR | inhibits | gene | 0.60 |
| CAT | activates | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| NEUROINFLAMMATION | activates | gene | 0.60 |
| TNF-Α | activates | gene | 0.60 |
| PARKINSON'S DISEASE | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-27 | 7 hypotheses Top: 0.710
neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.661
neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.604
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.77 · 2026-04-28
closed · Rounds: 4 · Score: 0.70 · 2026-04-21
closed · Rounds: 4 · Score: 0.70 · 2026-04-16
closed · Rounds: 4 · Score: 0.95 · 2026-04-16
Hypotheses and analyses mentioning NQO1 in their description or question text
No additional research found